2012
DOI: 10.1515/hsz-2012-0179
|View full text |Cite
|
Sign up to set email alerts
|

N-terminal acetylation of annexin A2 is required for S100A10 binding

Abstract: Annexin A2 (AnxA2), a Ca2+-regulated phospholipid binding protein involved in membrane-cytoskeleton contacts and membrane transport, exists in two physical states, as a monomer or in a heterotetrameric complex mediated by S100A10. Formation of the AnxA2-S100A10 complex is of crucial regulatory importance because only the complex is firmly anchored in the plasma membrane, where it functions in the plasma membrane targeting/recruitment of certain ion channels and receptors. The S100A10 binding motif is located i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
28
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 31 publications
(28 citation statements)
references
References 0 publications
0
28
0
Order By: Relevance
“…Bacterial expression of AnxA2 and its mutants was achieved by using a system that faithfully executed the posttranslational N-terminal modifications seen in mammalian cells, i.e. removal of the starting methionine and acetylation of the new N-terminal serine residue (13). Correct N-terminal processing of full-length AnxA2 enabled efficient S100A10 binding and thus correct reconstitution of the heterotetrameric AnxA2-S100A10 complex (herein referred to as A2t).…”
Section: Purification and Labeling Of Recombinant Anxa2 Derivatives-mentioning
confidence: 99%
See 2 more Smart Citations
“…Bacterial expression of AnxA2 and its mutants was achieved by using a system that faithfully executed the posttranslational N-terminal modifications seen in mammalian cells, i.e. removal of the starting methionine and acetylation of the new N-terminal serine residue (13). Correct N-terminal processing of full-length AnxA2 enabled efficient S100A10 binding and thus correct reconstitution of the heterotetrameric AnxA2-S100A10 complex (herein referred to as A2t).…”
Section: Purification and Labeling Of Recombinant Anxa2 Derivatives-mentioning
confidence: 99%
“…Thus, chemical modification of at least one of the exposed cysteines in AnxA2 (Cys-9, Cys-133, Cys-262) or S100A10 (Cys-61, Cys-82) interferes with complex formation. Therefore, to label A2t, the complex was first reconstituted from the purified individual subunits using established procedures (13) and then reacted with AlexaFluor 568 C 5 -maleimide. This yielded a fluorescently labeled complex in which both subunits were modified (Fig.…”
Section: Purification and Labeling Of Recombinant Anxa2 Derivatives-mentioning
confidence: 99%
See 1 more Smart Citation
“…It can exist in two physical states, as a monomer that is found predominantly in the cytosol and on early endosomes (5), and as a heterotetrameric complex (A2t) with its protein ligand S100A10 that is present in the subplasmalemmal region (6). S100A10, a member of the S100 family of small dimeric, EF-hand type Ca 2þ -binding proteins binds to the first 12 N-terminal residues of AnxA2, which form an amphipathic a-helix stabilized by posttranslational acetylation (7)(8)(9).…”
Section: Introductionmentioning
confidence: 99%
“…The N-terminus of AnxA2 binds into each of the two hydrophobic pockets of S100A10, forming a symmetric 2:2 complex of two AnxA2 molecules bound to a dimer of S100A10 (Ré ty et al, 1999). A requirement for this strong interaction is posttranslational modification of AnxA2, namely the removal of Met1 and acetylation of Ser2 at the new N-terminus (Nazmi et al, 2012;Becker et al, 1990). (p11) 2 (AnxA2) 2 is often localized near the plasma membrane, and this symmetric platform is proposed to be involved in the bridging of membrane vesicles and trafficking of proteins to the plasma membrane (van de Graaf et al, 2003;Umbrecht-Jenck et al, 2010).…”
Section: Introductionmentioning
confidence: 99%